In the pyramid drill see more.

Injuries among cheerleaders often result from gymnastic tumbling or maneuvers such as the pyramid and the basket throw. In the pyramid drill, the cheerleader at the head at the head usually after falling and landing on a hard surface see more . Throw the stunt in which stunt in which a cheerleader air air, often 6 to 20 feet, with three or four other cheerleaders. But injuries such as bruises, sprained ankles, shin – a head and neck injuries – can also occur dislocations, andrs are performing simple routines on unforgiving surfaces like gym floors. – Cheerleading has evolved into a physically demanding sport, the complex gymnastic maneuvers that of of injury to participants, says Raffy Mirzayan, orthopedic surgeon and Fellow of the AAOS. Cheerleading injuries can be prevented by increased spotter training, mandating the use of floor mats for complex stunts and promote safety education and proper training for coaches. .

– should practice performing A cheerleader and only under the guidance of a qualified and competent consultant or coach. – Make sure that the environment is suitable for the activity. For example, should cheerleading practice to take on a surface with the appropriate matting – not on hard surfaces like concrete or asphalt, wet or uneven surfaces or surfaces with obstructions.

LGDs -4665 proven to be safe and well in Phase I study in healthy volunteers on in the the fourth quarter 2007 tolerated. Statistically significant platelets increases were observed with both single and multiple daily doses. initiating of this Phase II trial marks an important milestone in the further which We LGDs -4665 look forward, a further ligand molecule to in trials advance for the treatment of an important medical condition We plan initiating additional clinical trials with a LGD. -4665 this year, said John L. Higgins, President and CEO of ligand Pharmaceuticals. A similar patient population TPO Drug Program of being focused on developing LGD 4665 multiple indications as well as promoting clinical strong next generation of molecules. We are were pleased to see to the March 2008 issue of the R & D Directions magazine LGDs -4665 among its ‘100 Large an Investigational medicinal drugs. ‘ .

see more